Multi-year data indicate that Net Loss is structurally weakening with slightly volatile variation. Financial forecasts anticipate softening toward approximately -1 M. Historical regression data from 2010 to 2026 show a standard deviation of 56,359,759 for Alignment Healthcare Net Loss. with r-squared of 0.07 . View All Fundamentals
Analyzing Alignment Healthcare's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Alignment Healthcare's current valuation and future prospects.
Latest Alignment Healthcare's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Alignment Healthcare LLC over the last few years. It is Alignment Healthcare's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alignment Healthcare's overall financial position and show how it may be relating to other accounts over time.
Alignment Net Income From Continuing Ops Regression Statistics
Arithmetic Mean
-64,893,171
Coefficient Of Variation
-86.85
Mean Deviation
43,689,449
Median
-44,732,000
Standard Deviation
56,359,759
Sample Variance
3176.4T
Range
194.3M
R-Value
-0.27
Mean Square Error
3137.8T
R-Squared
0.07
Significance
0.29
Slope
-3,033,868
Total Sum of Squares
50822.8T
Alignment Net Income From Continuing Ops History
2026
-1 M
2025
-978 K
2024
-128.1 M
2023
-157.9 M
2022
-149.6 M
2021
-195.3 M
2020
-22.9 M
Stock Overview, Methodology & Data Sources
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. The company was founded in 2013 and is based in Orange, California. Alignment Healthcare operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 847 people. As a large-cap equity, Alignment Healthcare is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 19.51, profit margin of -0.02%. Alignment Healthcare has a market cap of 3.5 B, ROE of -0.7%.
Methodology
Unless otherwise specified, financial data for Alignment Healthcare LLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Alignment (USA Stocks:ALHC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Alignment Healthcare LLC is covered by 13 analysts. 6 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Goldman Sachs, UBS Investment Research, Bank of America Securities, RBC Capital Markets, Jefferies, J.P. Morgan, Morgan Stanley, among others. Updates may occur throughout the day.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Understanding Alignment Healthcare LLC typically begins with financial statements and long-term trend review. Key ratios help frame profitability, efficiency, and growth context for Alignment Healthcare LLC Stock. Selected reports below provide context for Alignment Stock:
Analysis related to Alignment Healthcare should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Revenue Per Share
19.942
Quarterly Revenue Growth
0.444
Return On Assets
0.011
Return On Equity
-0.01
Alignment Healthcare LLC's market price can diverge from book value, the accounting figure shown on Alignment's balance sheet. Alignment Healthcare's market capitalization is 3.5 B. With a P/B ratio of 19.51, the market values Alignment Healthcare well above its book equity. Enterprise value stands at 3.22 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Alignment Healthcare's intrinsic value and market price are different measures derived from different inputs. For Alignment Healthcare, key inputs include a P/B ratio of 19.51, a profit margin of -0.02%, ROE of -0.7%, and revenue of 3.95 B. By contrast, market price reflects the level where buyers and sellers transact.